157 related articles for article (PubMed ID: 24509519)
1. Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT.
ter Voert EE; van Laarhoven HW; Kok PJ; Oyen WJ; Visser EP; de Geus-Oei LF
Nucl Med Commun; 2014 May; 35(5):472-7. PubMed ID: 24509519
[TBL] [Abstract][Full Text] [Related]
2. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
3. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
4. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?
Voltin CA; Mettler J; Boellaard R; Kuhnert G; Dietlein M; Borchmann P; Drzezga A; Kobe C
Nucl Med Commun; 2019 Mar; 40(3):249-257. PubMed ID: 30461699
[TBL] [Abstract][Full Text] [Related]
6. Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data.
Kim JH; Lee JS; Song IC; Lee DS
J Nucl Med; 2012 Dec; 53(12):1878-82. PubMed ID: 23081993
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
Seith F; Gatidis S; Schmidt H; Bezrukov I; la Fougère C; Nikolaou K; Pfannenberg C; Schwenzer N
Invest Radiol; 2016 Jan; 51(1):66-71. PubMed ID: 26348596
[TBL] [Abstract][Full Text] [Related]
8. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
[TBL] [Abstract][Full Text] [Related]
10. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
11. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
12. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Mawlawi O; Erasmus JJ; Munden RF; Pan T; Knight AE; Macapinlac HA; Podoloff DA; Chasen M
AJR Am J Roentgenol; 2006 Feb; 186(2):308-19. PubMed ID: 16423932
[TBL] [Abstract][Full Text] [Related]
13. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
Vera P; Ouvrier MJ; Hapdey S; Thillays M; Pesquet AS; Diologent B; Callonec F; Hitzel A; Edet-Sanson A; Ménard JF; Jardin F; Tilly H
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1943-52. PubMed ID: 17694309
[TBL] [Abstract][Full Text] [Related]
14. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
16. In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT.
Torigian DA; Dam V; Chen X; Saboury B; Udupa JK; Rashid A; Moghadam-Kia S; Alavi A
Hell J Nucl Med; 2013; 16(1):12-8. PubMed ID: 23529388
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18F-FDG-PET/CT.
Torigian DA; Lopez RF; Alapati S; Bodapati G; Hofheinz F; van den Hoff J; Saboury B; Alavi A
Hell J Nucl Med; 2011; 14(1):8-14. PubMed ID: 21512658
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
20. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
